RPG Life Sciences said on Tuesday that the company was debt free at the moment and was focused on domestic formulations.
In conversation with CNBC-TV18, Yugal Sikri, MD of RPG Life Sciences said, "We have paid all our loans. Therefore, we have a good amount of cushion now and the working capital situation continues to be good."
Speaking about the company's core business, he said, "Domestic formulation is our mainstay, our major focus areas and it continues to be focused upon."
Watch the video for more.
